| Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
|---|
| 08/08/2006 | US7087728 Crystal proteins which display stability to harsh environmental conditions; pronase resistance |
| 08/03/2006 | US20060173161 Protein-binding doxorubicin peptide derivatives |
| 08/03/2006 | US20060173160 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 08/03/2006 | US20060171961 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations |
| 07/27/2006 | WO2006050183A3 Inhibitors of sporeforming pathogens and applications of the same |
| 07/27/2006 | US20060167223 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 07/27/2006 | US20060166867 Argininamido-neomycin B conjugates; aminoglycoside antibiotics; for prevention and treatment of HIV infection |
| 07/27/2006 | CA2564112A1 Dalbavancin compositions for treatment of bacterial infections |
| 07/20/2006 | US20060160731 Peptide nucleic acids |
| 07/20/2006 | US20060160177 Peptide extended glycosylated polypeptides |
| 07/18/2006 | US7078380 comprises vancomycin-type antibiotics; peptide antibiotics; membrane proteins; defensins; for inhibiting peptidoglycan biosynthesis |
| 07/18/2006 | US7078195 Useful as anti-bacterial agents |
| 07/18/2006 | US7078185 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin |
| 07/18/2006 | US7078165 Gene expression of cells; genetic engineering using tripeptides; antiinflammatory agents; apoptosis;medical diagnosis |
| 07/13/2006 | WO2006052129A3 Antibiotic drosocin derivatives |
| 07/13/2006 | US20060154324 Prostate-specific antigen probes for optical imaging |
| 07/12/2006 | EP1678201A2 Hydrochloride salts of a glycopeptide phosphonate derivative |
| 07/11/2006 | US7074890 Process for preparing glycopeptide phosphonate derivatives |
| 07/11/2006 | US7074760 Bactericides; peptide antibiotics |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148679 Glycosolated enkephalin agents |
| 06/29/2006 | US20060142546 Immunogenic muc1 glycopeptides |
| 06/29/2006 | US20060141575 Secreted proteins and nucleic acids encoding them |
| 06/28/2006 | CN1261450C Antithrombotic compounds |
| 06/27/2006 | US7067620 Antibacterial agents |
| 06/27/2006 | US7067483 Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin |
| 06/27/2006 | US7067482 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/27/2006 | US7067481 Glycopeptide group is covalently linked to a pyridinium moiety of a cephalosporin group; reacting a glycopeptide containing (c6.c6.c6.c6.c6.c10n2.c13n2o.c13n2o ring) with a cephalosporin or salt in presence of a diacid |
| 06/22/2006 | US20060135410 Targeted delivery to legumain-expressing cells |
| 06/22/2006 | US20060134083 Compositions comprising sclareol or derivatives thereof and uses thereof |
| 06/15/2006 | WO2006061166A1 Pure vancomycin hydrochloride |
| 06/15/2006 | US20060128612 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/15/2006 | US20060128609 N¹- modified glycopeptides |
| 06/15/2006 | US20060128608 Novel chemical compounds and their use |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060127899 Active carbohydrate containing protecting reagents for chemical modifications, their production and use |
| 06/14/2006 | EP1263771B1 Chemoselective ligation by use of a phosphine |
| 06/13/2006 | US7060678 peptidomimetic analogs of VIP receptor binding inhibitors replacing the di-/tri-peptides having proline as one of the amino acids, or proline alone, with at leat one unit from enantiomorphic 4-(aminomethyl)tetrahydrofuran-2-carboxylic acid |
| 06/08/2006 | WO2006059227A1 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosurgery |
| 06/08/2006 | US20060122382 Method of manufacturing labelled oligonucleotide conjugates |
| 06/08/2006 | US20060122369 In vacuo glycation of proteins |
| 06/08/2006 | CA2588801A1 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosurgery |
| 06/07/2006 | EP1664127A1 Synthetic polysaccharide antigens for immunological intervention in disease |
| 06/07/2006 | EP1664083A1 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation |
| 06/07/2006 | EP0969873B1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 06/07/2006 | CN1784244A Prodrugs cleavable by CD26 |
| 06/07/2006 | CN1781916A Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/30/2006 | CA2184899C Highly reactive esters of carboxy polysaccharides and novel carboxy polysaccharides derived therefrom |
| 05/25/2006 | US20060111277 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water |
| 05/24/2006 | EP1383480A4 Lipid-comprising drug delivery complexes and methods for their production |
| 05/17/2006 | EP1657249A1 Antibiotic drosocin derivatives |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/16/2006 | US7045310 Measuring the concentration of preferential analyte in sample; obtain samples, incubate with binding particles, determine concentration of detectable particles |
| 05/11/2006 | WO2004022578A3 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 05/11/2006 | US20060100415 aminalkylphosphonate-substituted vancomycin; chromatography; DIVINYLBENZENE-STYRENE COPOLYMER |
| 05/10/2006 | EP1210355B1 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 05/09/2006 | US7041637 Echinocandin/carbohydrate complexes |
| 05/04/2006 | WO2006045627A1 Purification of glycopeptides |
| 05/04/2006 | CA2577854A1 Purification of glycopeptides |
| 05/02/2006 | US7038010 Agents and methods for promoting bone growth |
| 05/02/2006 | US7037898 Tumor-activated prodrug compounds and treatment |
| 04/26/2006 | EP1648492A2 A novel antiproliferative factor and methods of use |
| 04/20/2006 | US20060084090 Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI) |
| 04/20/2006 | US20060083847 purified glycopeptide or peptide having the chemical structure containing valine-asparagine-histidine- threonine tetrapeptide bonded to a sugar such as xylose, mannose or fucose; strong effect of improving taste such as the function of imparting the kokumi taste to foods |
| 04/18/2006 | US7030105 Method of synthesis of β-thiolato cobalamin compounds |
| 04/12/2006 | EP1644382A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0866878B1 Detection of mammary tumor virus-like sequences in human breast cancer |
| 04/11/2006 | US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/05/2006 | EP1641730A1 Recombined molecules and preparation thereof |
| 04/05/2006 | CN1249081C Glycopeptide derivatives and pharmaceutical compositions containing same |
| 03/30/2006 | US20060069238 Synthetic glyco-lipo-peptides as vaccines |
| 03/28/2006 | US7018814 Process of purifying vancomycin hydrochloride |
| 03/23/2006 | US20060063706 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals; treating infection caused by methicillin-resistant Staphylococcus aureus |
| 03/22/2006 | EP1635858A2 Targeted delivery to legumain-expressing cells |
| 03/22/2006 | CN1246036C Process for preparing glycopeptide phosphonate derivatives |
| 03/21/2006 | US7015315 first region having 2'-O-alkyl substituted nucleotide units where the alkyl has at least 2 carbon atoms, and a second region having 2'-deoxy sugar moieties, and which includes phosphorothioate linkages; nuclease resistance; hybridizes to single stranded DNA or RNA |
| 03/21/2006 | US7015307 Process for purifying glycopeptide phosphonate derivatives |
| 03/21/2006 | US7015305 Process for preparing glycopeptide derivatives |
| 03/16/2006 | WO2004099231A3 Glycopegylation methods and proteins/peptides produced by the methods |
| 03/16/2006 | US20060058503 Process for preparing glycopeptide derivatives |
| 03/15/2006 | EP1633759A1 Cross-linked glycopeptide - cephalosporin antibiotics |
| 03/15/2006 | CN1747970A Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 03/14/2006 | US7011834 Immunomodulating dimers |
| 03/07/2006 | US7008923 Glycopeptide phosphonate derivatives |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/01/2006 | CN1741810A Glycopeptide antibiotic derivatives |
| 02/28/2006 | US7005498 analogues of immunogenic human Her2 proteins comprising amino acid sequences modified foreign T-helper lymphocyte epitopes, used for immunotherapy |
| 02/23/2006 | US20060040314 Methods for screening polypeptides |
| 02/22/2006 | CN1738643A Composition and method for preventing or treating a virus infection |
| 02/21/2006 | US7001982 Non-natural C-linked carbo-β-peptides with robust secondary structures |
| 02/16/2006 | WO2006017180A2 Glycopeptide dimers and uses thereof |
| 02/16/2006 | US20060035305 Synthetic peptides, conjugation reagents and methods |
| 02/15/2006 | EP1624897A2 Hiv prodrugs cleavable by cd26 |
| 02/09/2006 | US20060030521 Remodeling and glycoconjugation of peptides |
| 02/08/2006 | EP1622635A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 02/07/2006 | US6995138 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/02/2006 | US20060025332 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/02/2006 | US20060024779 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |